Corporate Banner
Satellite Banner
qPCR
Scientific Community
 
Join | Sign in
Home>News

  News Archive

QIAGEN Signs Ninth Master Collaboration Agreement for Companion Diagnostics
Thursday, November 13, 2014
Master collaboration agreement is a framework for developing and commercializing QIAGEN companion diagnostics, paired with new or existing products.

Horizon Discovery Group plc Establishes Scientific Advisory Board for Horizon Diagnostics Business Unit
Tuesday, November 11, 2014
The Scientific Advisory Board will recommend improvements needed in laboratories adopting Companion Diagnostic assays.

RainDance Appoints Martin M. Coyne II and Glenn P. Muir to Board of Directors
Friday, November 07, 2014
Executives bolster board expertise as Company expands its reach into leading genomics research labs by enabling non-invasive Fluid Biopsy™ applications.

InVentis Technologies to Distribute TriLink Products in India
Friday, November 07, 2014
InVentis Technologies will market TriLink’s complete line of nucleic acid-based products.

PositiveID Corporation Signs Agreement With U.S. Special Operations Command
Thursday, November 06, 2014
PositiveID enters cooperative research and development agreement with Special Operations Research, Development, & Acquisition Center, Science & Technology Directorate, for the continued development of the company's Firefly Dx System.

Clontech Licenses CRISPR/CAS9 Technology From Broad Institute
Tuesday, October 28, 2014
Clontech Laboratories, Inc. have entered into a non-exclusive license agreement with the Broad Institute to access intellectual property related to the CRISPR/Cas9 gene editing system.

HudsonAlpha Named Latest RainDance Center of Excellence
Tuesday, October 28, 2014
Premier biotech research center adopts complete RainDance product portfolio to enhance next-generation sequencing and digital PCR services offering.

Transgenomic Announces $2.375 Million Private Placement Financing
Tuesday, October 28, 2014
Net proceeds from this offering will support Company’s ICE COLD-PCR™ technology.

TGen and NAU Patent for New Pandemic Flu Test is Approved
Tuesday, October 21, 2014
H1N1 assay benefits patients by helping doctors determine if infections are resistant to available flu treatments.

<< 4 5 6 7 8 9 10 >>
Showing Results 61 - 70 of 709
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters